STOCK TITAN

[SCHEDULE 13G/A] Adagene Inc. Amended Passive Investment Disclosure

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Adagene Inc. shareholder Vincent C. Smith and related entities filed an amended Schedule 13G reporting significant ownership of the company’s Ordinary Shares. Mr. Smith may be deemed to beneficially own 5,095,351 Ordinary Shares, or 8.7% of the class, including shares held directly and through affiliated entities.

The Vincent C. Smith, Jr. 2025 Annuity Trust beneficially owns 3,608,019 Ordinary Shares, representing 6.1% of the class, while VCS Master Holdings GP holds 185,701 Ordinary Shares, or 1.0%. These percentages are based on 58,914,087 Ordinary Shares outstanding as of June 30, 2025. The filing states the securities were not acquired to change or influence control of Adagene.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: (1) Includes sole voting and dispositive power over 1,301,631.25 Ordinary Shares held directly, and shared voting and dispositive power over (i) 3,608,018.75 Ordinary Shares held by The Vincent C. Smith, Jr. 2025 Annuity Trust and (ii) 185,701.25 Ordinary Shares held by VCS Master Holdings GP. Mr. Smith is a trustee of The Vincent C. Smith, Jr. 2025 Annuity Trust therefore may be deemed to have beneficial ownership of the shares held thereby. Mr. Smith is the grantor of all of the trusts that are partners of VCS Master Holdings GP and disclaims beneficial ownership of the shares held thereby. (2) Represents Ordinary Shares held by the Reporting Person. There is no CUSIP number assigned to the Ordinary Shares. CUSIP number 005329 107 has been assigned to the ADSs of the Issuer, which are quoted on NASDAQ Stock Market under the symbol "ADAG." Each ADS represents one and one quarter Ordinary Share.


SCHEDULE 13G




Comment for Type of Reporting Person: (1) Mr. Smith is a trustee of The Vincent C. Smith, Jr. 2025 Annuity Trust and therefore may be deemed to have beneficial ownership of the shares held thereby. (2) Represents the ordinary shares, par value $0.0001 per share of the Issuer ("Ordinary Shares") held by the Reporting Person. There is no CUSIP number assigned to the Ordinary Shares. CUSIP number 005329 107 has been assigned to the American depositary shares ("ADSs") of the Issuer, which are quoted on NASDAQ Stock Market under the symbol "ADAG." Each ADS represents one and one quarter Ordinary Share.


SCHEDULE 13G




Comment for Type of Reporting Person: (1) Mr. Smith is the grantor of all of the trusts that are partners of VCS Master Holdings GP, and disclaims beneficial ownership of the shares held thereby. (2) Represents Ordinary Shares held by the Reporting Person. There is no CUSIP number assigned to the Ordinary Shares. CUSIP number 005329 107 has been assigned to the ADSs of the Issuer, which are quoted on NASDAQ Stock Market under the symbol "ADAG." Each ADS represents one and one quarter Ordinary Share.


SCHEDULE 13G



Smith Vincent C
Signature:/s/ Vincent C. Smith
Name/Title:Individual
Date:01/29/2026
The Vincent C. Smith, Jr. 2025 Annuity Trust
Signature:/s/ Vincent C. Smith
Name/Title:Trustee
Date:01/29/2026
VCS Master Holdings GP
Signature:/s/ Jerry Rickmeyer
Name/Title:Trustee & Partner
Date:01/29/2026
Adagene Inc.

NASDAQ:ADAG

ADAG Rankings

ADAG Latest News

ADAG Latest SEC Filings

ADAG Stock Data

137.15M
41.13M
4.7%
31.63%
0.02%
Biotechnology
Healthcare
Link
China
Suzhou